A single-arm confirmatory study to evaluate the efficacy of nonsurgical therapy for HER2-positive early breast cancer with clinical complete response after primary systemic therapy (JCOG1806: AMATERAS-BC study).

Tomomi Fujisawa,Tadahiko Shien,Hiroji Iwata,Hideo Shigematsu,Taro Shibata,Keita Sasaki,Yuko Takahashi

A single-arm confirmatory study to evaluate the efficacy of nonsurgical therapy for HER2-positive early breast cancer with clinical complete response after primary systemic therapy (JCOG1806: AMATERAS-BC study).

2021

Tomomi Fujisawa
Tadahiko Shien
Hiroji Iwata
Hideo Shigematsu
Taro Shibata
Keita Sasaki
Yuko Takahashi

TPS601Background: The surgical treatment is a standard therapy for early breast cancer (EBC) after primary systemic therapy (PST). In more than half of HER2 positive (HER2(+)) breast cancer, pathol...

Keywords:

Systemic therapy
clinical complete response
Internal medicine
Medicine
surgical treatment
Oncology
standard therapy
early breast cancer
Breast cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations